Pros and cons of peg-interferon versus nucleos(t)ide analogues for treatment of chronic hepatitis B

Milan Sonneveld, HLA Janssen

Research output: Contribution to journal › Article › Academic › peer-review

Original languageUndefined/Unknown
Pages (from-to)91-98
Number of pages8
JournalCurrent Hepatitis Reports
Volume9
Publication statusPublished - 2010

Research programs

  • EMC MM-04-20-02-A

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  • SDG 3 - Good Health and Well-being

Cite this